Research Purposes Only
This website contains information about research peptides intended strictly for laboratory and scientific research. You must be 18 years or older to enter.
By entering you confirm you are 18+ and agree that all products are for research use only. Not for human consumption.
hGH Fragment 176–191
AOD 9604 is a modified fragment of human growth hormone (hGH) corresponding to amino acids 176–191. Studied for its role in lipolysis, fat metabolism regulation, and adipose tissue research without the proliferative effects of full-length hGH.
AOD 9604 (Anti-Obesity Drug 9604) is a synthetic peptide fragment derived from the C-terminus of human growth hormone, specifically the amino acid sequence 176–191 with a tyrosine residue added at the N-terminus. Unlike full-length hGH, AOD 9604 does not bind to the IGF-1 receptor and does not exhibit mitogenic or proliferative activity, making it a highly selective research tool for studying fat metabolism. Research has demonstrated its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat accumulation) in adipose tissue through mechanisms involving beta-3 adrenergic receptors. It is widely used in metabolic research, obesity biology, and adipose tissue studies.
GLP-1 Receptor Agonist
Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist. Used extensively in metabolic and endocrine research to study insulin secretion, glucagon suppression, and energy homeostasis.
Dual GIP/GLP-1 Receptor Agonist
Tirzepatide is a novel dual GIP/GLP-1 receptor agonist. Studied for its combined incretin effects on glucose metabolism, insulin sensitivity, and energy regulation in metabolic research settings.
Nicotinamide Adenine Dinucleotide
NAD+ is a critical coenzyme found in all living cells, central to redox reactions and energy metabolism. Studied extensively for its roles in sirtuin activation, DNA repair, and cellular aging research.
For Research Purposes Only · Not intended for human consumption